Cargando…

TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast

BACKGROUND: Phyllodes tumors are rare fibroepithelial neoplasms of the breast, which carry the potential risk of local recurrence and metastasis. Phyllodes tumors share several histological features with fibroadenomas, and no widely accepted markers for distinguishing these lesions have been identif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Masayuki, Ogawa, Reiko, Yoshida, Hiroshi, Maeshima, Akiko, Kanai, Yae, Kinoshita, Takayuki, Hiraoka, Nobuyoshi, Sekine, Shigeki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Genetics & Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647876/ https://www.ncbi.nlm.nih.gov/pubmed/26355235 http://dx.doi.org/10.1038/bjc.2015.326

Ejemplares similares

Frequent MED12 mutations in phyllodes tumours of the breast
por: Yoshida, M, et al.
Publicado: (2015)

Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations
por: Otsuji, Kazutaka, et al.
Publicado: (2020)

MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours
por: Garcia-Dios, Diego A, et al.
Publicado: (2018)

MED12 exon 2 mutations in phyllodes tumors of the breast
por: Nagasawa, Satoi, et al.
Publicado: (2015)

Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms
por: Nishikawa, G, et al.
Publicado: (2013)

TERT promoter hotspot mutations in breast cancer
por: Shimoi, Tatsunori, et al.
Publicado: (2017)

Frequent somatic TERT promoter mutations and CTNNB1 mutations in hepatocellular carcinoma
por: Lee, Seung Eun, et al.
Publicado: (2016)

MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways
por: Laé, Marick, et al.
Publicado: (2016)

Mutation of MED12 is not a frequent occurrence in prostate cancer of Korean patients
por: Yoon, Nara, et al.
Publicado: (2017)

TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma
por: Griewank, Klaus G., et al.
Publicado: (2013)

Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast
por: Tsang, Julia Y. S., et al.
Publicado: (2018)

TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations
por: Williams, Erik A., et al.
Publicado: (2018)

Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12
por: Mäkinen, Netta, et al.
Publicado: (2016)

TERT promoter mutations and monoallelic activation of TERT in cancer
por: Huang, F W, et al.
Publicado: (2015)

Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice as an Animal Model of Spontaneous Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2011)

E‐Cadherin Gene Mutations in Signet Ring Cell Carcinoma of the Stomach
por: Muta, Hiromi, et al.
Publicado: (1996)

The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer
por: Li, Chong, et al.
Publicado: (2015)

TERT promoter mutations in melanoma survival
por: Nagore, Eduardo, et al.
Publicado: (2019)

Significance of TERT and ATRX mutations in glioma
por: Liu, Jiayu, et al.
Publicado: (2019)

The Solo Play of TERT Promoter Mutations
por: Hafezi, François, et al.
Publicado: (2020)

TERT Promoter Mutations and Telomerase in Melanoma
por: Guo, Yuchen, et al.
Publicado: (2022)

Differences in Ovarian and Other Cancers Risks by Population and BRCA Mutation Location
por: Sekine, Masayuki, et al.
Publicado: (2021)

Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling
por: Endo, Yutaka, et al.
Publicado: (2021)

DNA methylation status of the SPHK1 and LTB genes underlies the clinicopathological diversity of non-alcoholic steatohepatitis-related hepatocellular carcinomas
por: Tsuda, Noboru, et al.
Publicado: (2022)

Unique mutation portraits and frequent COL2A1 gene alteration in chondrosarcoma
por: Totoki, Yasushi, et al.
Publicado: (2014)

TERT Promoter Mutations Increase Sense and Antisense Transcription from the TERT Promoter
por: Hafezi, François, et al.
Publicado: (2021)

Sequencing Alpha-1 MZ Individuals Shows Frequent Biallelic Mutations
por: Foil, Kimberly E., et al.
Publicado: (2018)

Molecular Mechanisms of Uterine Leiomyosarcomas: Involvement of Defect in LMP2 Expression
por: Hayashi, Takuma, et al.
Publicado: (2008)

Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia
por: Togasaki, E, et al.
Publicado: (2017)

TERT promoter mutations and gene amplification: Promoting TERT expression in Merkel cell carcinoma
por: Xie, Hong, et al.
Publicado: (2014)

TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation
por: Vallarelli, Andrelou F., et al.
Publicado: (2016)

Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers
por: Stern, Josh Lewis, et al.
Publicado: (2015)

Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression
por: Salgado, Catarina, et al.
Publicado: (2020)

Hotspot mutation profiles of AKT1 in Asian women with breast and endometrial cancers
por: Shimoi, Tatsunori, et al.
Publicado: (2021)

Frequent MAGE Mutations in Human Melanoma
por: Caballero, Otavia L., et al.
Publicado: (2010)

Germline PMS2 mutation screened by mismatch repair protein immunohistochemistry of colorectal cancer in Japan
por: Sugano, Kokichi, et al.
Publicado: (2016)

Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas
por: Tian, Ying, et al.
Publicado: (2020)

An Integrated Epigenomic and Genomic View on Phyllodes and Phyllodes-like Breast Tumors
por: Hench, Juergen, et al.
Publicado: (2022)

Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancers
por: Reinisch, Mattea, et al.
Publicado: (2021)

Telomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) Mutations
por: Diaz de Leon, Alberto, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_abrfgg00msklb4u8q3iial9c7n